| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Filius Bart is a Director at ProQR Therapeutics N.V.. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $564K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 17, 2026 | PRQR Proqr Therapeutics N.V. | Director | Buy | 150,000 | $1.72 | $257,925.00 | +100.0% |